For example, a contemporary meta-analysis of studies from 2020 to 2024 (n ≈ 985 participants) shows markedly lower circulating levels of both total and acylated ghrelin in PD patients compared to healthy individuals. This evidence concerns the gene GHRL and Parkinson disease.